CHI3L1 and Alzheimer disease: The present study demonstrated the usefulness of YKL-40 CSF levels in the diagnosis of AD and the differentiation from MCI, and has also shown that YKL-40 levels can be used, along with other biomarkers for the prognosis of MCI and the likelihood of progression to AD.